As the stock market hits new highs on all the major indexes seemingly daily, it appears that the market has moved to a “risk on” scenario. This coming after a very tough August when things looked rather bleak. There...
Tailwinds' Take: with ANIX ready to file an IND within weeks, this patent helps secure their IP around a very promising potential cure for breast cancer. If the IND is approved, initial safety data will be available from an...
Tailwinds’ Take: Dr. Ostuni joining the Scientific Advisory Board (SAB) of Anixa could have major significance to the Company. Investors should really start paying attention to the recent additions to the SAB as they are telling signals into the...
Tailwinds' Take: the gating factor for Cchek obtaining CLIA approval is recording a sufficient quantity of samples. The data continues to be even better than seen in earlier trials and the value of this product (and the platform) is...
Tailwinds' Take: With CLIA approval for Cchek in prostate cancer expected within weeks, Anixa is already moving forward on a second indication. The recent hire of a solid head of the diagnostics' area and the success they are showing...
Tailwinds' Take: hiring an executive to lead business development is key for Cchek as Anixa will be looking to move the product onwards towards a national diagnostic lab company sometime during 2020. SAN JOSE, Calif., Oct. 15, 2019 /PRNewswire/ -- Anixa...
Tailwinds' Take: the key takeaway from this is that the top scientists in the world are now coming on board to work with Anixa. Dr. Frazer is credited with enabling the creation of the first and only cancer vaccine...
I tend to be very much a buy and hold investor. I take positions, add to them as I gain confidence and generally let them ride. I do add to stocks on weakness and will trim some into strength....
Tailwinds' Take: endorsement from KOL's like the Potomac Urology Center is key to getting Cchek broad acceptance and a maximum valuation when they eventually partner with a large national lab sometime in the next year or so. SAN JOSE, Calif.,...
Now that the summer is over, and the fall conference season is ahead I thought it might be a good time for an interview with Dr. Amit Kumar, CEO of Anixa, for an update on their programs. With several...
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.